Health Populi
MARCH 13, 2025
used by nearly one-half of people based on a survey of 2,000 consumers conducted for Propel Software. The Propel study’s insights build on what we know is a growing ethos among health consumers seeking to take more control over their health care and the rising costs of medical bills and out-of-pocket expenses.
Mobi Health News
SEPTEMBER 14, 2022
According to a survey by the American Medical Association, 93% of physicians felt there was some advantage or a definite advantage to using digital health tools in 2022, compared with 85% in 2016.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
OCTOBER 30, 2024
Most consumers using digital health devices felt more trust in the technology when coupled with doctors’ office reviews — another lens on the importance of trust-equity between patients and physicians. For the study, Propel Software engaged Talker Research to conduct a survey among 2,000 U.S.
Mobi Health News
FEBRUARY 5, 2020
A majority of employers, meanwhile, said they are viewing workforce digital health offerings as a worthwhile investment, according to a new Mercer Marsh Benefits, Mercer and Oliver Wyman report.
Speaker: Mintu Turakhia M.D. M.A.S., Consulting Head of Medical, 100Plus | Mike Wurm, Director of Product and Strategy, 100Plus | Daniel Gasparini, Director of Sales | Nadia Ziyadeh-Hammad, LVN, RPM Coordinator, Greenville Healthcare Associates
After wide adoption of 100Plus' RPM framework by providers and health care networks, we decided to perform a quality analysis to uncover the impact of our RPM system on key health metrics, and surveyed providers to gather perspectives on how 100Plus' RPM has affected and improved care delivery. Mintu Turakhia M.D.
Mobi Health News
DECEMBER 14, 2021
Rock Health’s 2021 Digital Health Consumer Adoption Survey also found an increase in live video telemedicine and a decrease in satisfaction with telehealth compared with in-person care.
Mobi Health News
DECEMBER 2, 2022
A GSR Ventures survey of 50 investors reveals return on investment and clinical validation would be vital to a company's success next year.
Expert insights. Personalized for you.
177 
Let's personalize your content